Recital 36, Regulation (EU) 2025/787

In forcesince 24 Apr 2025

For the active substance penthiopyrad, the application for the renewal of the approval has been made public by the Authority. Pursuant to Article 12 of Implementing Regulation (EU) 2020/1740, the draft renewal assessment report received from the rapporteur Member State is under examination by the Authority, to conclude whether it contains all the relevant information in the agreed format, before circulating it to the applicant and to the other Member States. Therefore, the Authority needs additional time to conclude the risk assessment, including the organisation of a public consultation and, where appropriate, a consultation of experts. Additional time is also needed for the Commission to adopt the ensuing risk management decisions.